Individuals who used GLP-1RAs for 0.5, 1, and 1.5 years had IRRs close to 1.0, with no significant decrease in MACE risk at three years, although these estimates varied across specific treatment strategies defined by prior duration and subsequent exposure patterns
However, cipemastat, a selective MMP inhibitor, paradoxically increased cavitation, immunopathology, and mortality in a murine model of cavitary TB [139]
doi: 10.1136/jitc-2021-002899 83 AparicioBReprazDRuizMLlopizDSilvaLVercherEet al
Inhibition of Glucagon Secretion Glucagon is a hormone that raises blood sugar levels by promoting hepatic glucose production
They work by mimicking the action of the GLP-1 hormone, which is naturally produced in the gut when we eat